NYXH

Nyxoah (NYXH)

Nyxoah SA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NYXH

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/04	05:30	GlobeNewswire Inc.	Nyxoah to Participate in the Jefferies Global Healthcare Conference	NASDAQ:NYXH	Nyxoah SA
2024/06/04	05:24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/06/04	05:15	GlobeNewswire Inc.	Information on the total number of voting rights and shares	NASDAQ:NYXH	Nyxoah SA
2024/06/04	05:05	GlobeNewswire Inc.	Publication relating to transparency notifications	NASDAQ:NYXH	Nyxoah SA
2024/06/01	05:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/05/31	15:00	GlobeNewswire Inc.	Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares	NASDAQ:NYXH	Nyxoah SA
2024/05/31	06:20	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NYXH	Nyxoah SA
2024/05/30	05:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/05/29	05:30	GlobeNewswire Inc.	Information on the Total Number of Voting Rights and Shares	NASDAQ:NYXH	Nyxoah SA
2024/05/25	05:42	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/05/25	05:40	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NYXH	Nyxoah SA
2024/05/23	22:59	GlobeNewswire Inc.	Nyxoah Announces Pricing of Offering	NASDAQ:NYXH	Nyxoah SA
2024/05/23	05:17	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NYXH	Nyxoah SA
2024/05/23	05:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/05/23	05:10	GlobeNewswire Inc.	Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program	NASDAQ:NYXH	Nyxoah SA
2024/05/23	05:05	GlobeNewswire Inc.	Nyxoah Announces Proposed Offering of Ordinary Shares	NASDAQ:NYXH	Nyxoah SA
2024/05/15	05:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/05/15	05:05	GlobeNewswire Inc.	Nyxoah Reports First Quarter 2024 Financial and Operating Results	NASDAQ:NYXH	Nyxoah SA
2024/05/14	05:30	GlobeNewswire Inc.	Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024	NASDAQ:NYXH	Nyxoah SA
2024/05/10	14:00	GlobeNewswire Inc.	Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024	NASDAQ:NYXH	Nyxoah SA
2024/04/12	05:30	GlobeNewswire Inc.	Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer	NASDAQ:NYXH	Nyxoah SA
2024/03/30	05:30	GlobeNewswire Inc.	Information on the total number of voting rights and shares	NASDAQ:NYXH	Nyxoah SA
2024/03/25	15:05	GlobeNewswire Inc.	Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation	NASDAQ:NYXH	Nyxoah SA
2024/03/20	05:05	GlobeNewswire Inc.	Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints	NASDAQ:NYXH	Nyxoah SA
2024/03/06	06:13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA
2024/03/06	06:05	GlobeNewswire Inc.	Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results	NASDAQ:NYXH	Nyxoah SA
2024/03/01	06:30	GlobeNewswire Inc.	Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	NASDAQ:NYXH	Nyxoah SA
2024/02/16	06:30	GlobeNewswire Inc.	Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024	NASDAQ:NYXH	Nyxoah SA
2024/02/15	06:17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NYXH	Nyxoah SA
2024/01/18	06:12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NYXH	Nyxoah SA